Epidemiología de los tumores genitourinarios en una década

Background

There are no reliable epidemiologic registers of cancer in Mexico. Genitourinary cancer represents 20% of all cancers. In 2012, prostate cancer represented 21.4% of all cancers, kidney cancer 2.13%, bladder cancer 2.2%, and testicular cancer 2.7%. An epidemiologic register carried out in 2011 reported a lower incidence than that described in the international literature.

Aim

To know the number of new cases of the different tumors affecting the genitourinary tract.

Material and methods

An analytic, retrospective study was conducted, carrying out a review of the medical records with genitourinary cancer diagnoses within the time frame of January 2004 and June 2014 obtained from the Department of Histology of this institution.

Results

We found a total of 861 cases. Prostate cancer represented 43.4% of the total (12-56.4%/year), cancer of the penis 5.6% (2.2-11.4%/year), kidney cancer 15.3% (11-24%/year), cancer of the upper urinary tract 1.27% (0.1-0.34%/year), bladder cancer 13% (2-22.7%/year), and testicular cancer 21.2% (13.2-56.2%/year).

Discussion

The results of our review are consistent with those reported in the international literature. The epidemiology of cancer in Mexico is underestimated due to the lack of reliable registers.

Conclusions

In our case series we observed an increase in the detection of new cases of genitourinary tumors. Increased knowledge in relation to the epidemiology of genitourinary cancer in Mexico is necessary so that the resources for treating these neoplasias can be optimized.